Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Res ; 1683: 17-26, 2018 03 15.
Article in English | MEDLINE | ID: mdl-29360465

ABSTRACT

Stellera chamaejasme L. (Thymelaeaceae) is a toxic perennial herb and widespread in Mongolia and the northern parts of China. Previous studies have revealed that Neochamaejasmin A (NCA), one of the main active ingredients in the plant roots, has many bioactivities such as inhibiting the P-gp-mediated efflux. But whether NCA affects ion channels is unknown. Here the whole cell patch clamp technique was used to investigate whether NCA affects ion channels, especially how it inhibits KV1.4. Mutagenesis and structure-based molecular simulation were used for analysis of inhibition mechanism and identification of binding site. Among all the channels assayed, KV1.4 stood out as the one on which NCA showed strongest inhibition activity with IC50 of 7.55 µM. Compared with NCA's isomerides, neochamaejasmin B (NCB) and chamaechromone (CMC), NCA also exhibited superior inhibition ability on KV1.4. Three mutations, V549A, A553V and V560A, occurred inside the pore, were found to significantly alleviate the NCA blocking effects, suggesting that they are the important binding sites of NCA. Structure-based modelling showed that the phenolic hydroxyl group of NCA can form hydrogen bonds with main chains of Val549 and Ala553 in IS6 and IVS6 segment respectively, which support our in vitro results. In conclusion, data suggest that NCA might inhibit KV1.4 channels via direct binding to the pore domain.


Subject(s)
Biflavonoids/pharmacology , Flavones/metabolism , Kv1.4 Potassium Channel/drug effects , Thymelaeaceae/drug effects , Animals , Biochemical Phenomena/drug effects , Biophysical Phenomena/drug effects , CHO Cells , Cricetulus , Humans , Molecular Structure
2.
Eur J Neurosci ; 29(10): 1943-50, 2009 May.
Article in English | MEDLINE | ID: mdl-19453640

ABSTRACT

Arachidonic acid (AA) is a free fatty acid membrane-permeable second messenger that is liberated from cell membranes via receptor- and Ca(2+)-dependent events. We have shown previously that extremely low [AA](i) (1 pm) inhibits the postsynaptic voltage-gated K(+) current (I(A)) in hippocampal neurons. This inhibition is blocked by some antioxidants. The somatodendritic I(A) is mediated by Kv4.2 gene products, whereas presynaptic I(A) is mediated by Kv1.4 channel subunits. To address the interaction of AA with these alpha-subunits we studied the modulation of A-currents in human embryonic kidney 293 cells transfected with either Kv1.4 or Kv4.2 rat cDNA, using whole-cell voltage-clamp recording. For both currents 1 pm [AA](i) inhibited the conductance by > 50%. In addition, AA shifted the voltage dependence of inactivation by -9 (Kv1.4) and +6 mV (Kv4.2), respectively. Intracellular co-application of Trolox C (10 microm), an antioxidant vitamin E derivative, only slowed the effects of AA on amplitude. Notably, Trolox C shifted the voltage dependence of activation of Kv1.4-mediated I(A) by -32 mV. Extracellular Trolox for > 15 min inhibited the AA effects on I(A) amplitudes as well as the effect of intracellular Trolox on the voltage dependence of activation of Kv1.4-mediated I(A). Extracellular Trolox further shifted the voltage dependence of activation for Kv4.2 by +33 mV. In conclusion, the inhibition of maximal amplitude of Kv4.2 channels by AA can explain the inhibition of somatodendritic I(A) in hippocampal neurons, whereas the negative shift in the voltage dependence of inactivation apparently depends on other neuronal channel subunits. Both AA and Trolox potently modulate Kv1.4 and Kv4.2 channel alpha-subunits, thereby presumably tuning presynaptic transmitter release and postsynaptic somatodendritic excitability in synaptic transmission and plasticity.


Subject(s)
Arachidonic Acid/pharmacology , Kv1.4 Potassium Channel/drug effects , Shal Potassium Channels/drug effects , Synaptic Transmission/drug effects , Animals , Antioxidants/pharmacology , Brain/physiology , Cells, Cultured , Chromans/pharmacology , Humans , Ion Channel Gating/drug effects , Ion Channel Gating/physiology , Kv1.4 Potassium Channel/metabolism , Membrane Potentials/drug effects , Membrane Potentials/physiology , Neuronal Plasticity/drug effects , Neuronal Plasticity/physiology , Patch-Clamp Techniques , Presynaptic Terminals/drug effects , Presynaptic Terminals/metabolism , Rats , Shal Potassium Channels/metabolism , Synaptic Transmission/physiology , Transfection
3.
Biol Pharm Bull ; 32(4): 614-8, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19336893

ABSTRACT

Kv1.4 channel belongs to the family of voltage-gated potassium channels that mediate transient and rapidly inactivating A-type currents and N-type inactivation. This N-type inactivation can be removed by the deletion of N-terminal domains, which exhibit non-inactivating currents and C-type inactivation. In our previous report, we demonstrated that 20(S)-ginsenoside Rg(3) (Rg(3)), one of the active ingredients of ginseng saponins, inhibits human Kv1.4 (hKv1.4) channel currents through the interaction with amino acids, including Lys (K) residue, which is known as K(+) activation and the extracellular tetraethylammonium (TEA) binding site. In the present study, we examined the effects of Rg(3) on hKv1.4 channel currents without the N-terminal rapid inactivation domain. We constructed hKv1.4Delta2-61 channels by N-terminal deletion of 2-61 amino acid residues. We investigated the effect of Rg(3) on hKv1.4Delta2-61 channel currents. We found that Rg(3) preferentially inhibited non-inactivating outward currents rather than peak outward currents of hKv1.4Delta2-61 channels. The mutation of K531 hKv1.4Delta2-61 to K531Y hKv1.4Delta2-61 and raising of extracellular [K(+)](o) abolished Rg(3) inhibitions on non-inactivating outward currents. Rg(3) treatment increased the C-type inactivation rate, but raising the extracellular [K(+)](o) reversed Rg(3) action. These results provide additional evidence that K531 residue also plays an important role in the Rg(3)-mediated non-inactivating current blockages and in Rg(3)-mediated increase of the C-type inactivation rate in hKv1.4Delta2-61 channels.


Subject(s)
Ginsenosides/pharmacology , Kv1.4 Potassium Channel/drug effects , Potassium Channel Blockers , Animals , Dose-Response Relationship, Drug , Extracellular Space/drug effects , Extracellular Space/metabolism , Humans , Kv1.4 Potassium Channel/biosynthesis , Kv1.4 Potassium Channel/genetics , Microinjections , Mutagenesis, Site-Directed , Oocytes/drug effects , Oocytes/metabolism , Patch-Clamp Techniques , Potassium/metabolism , Xenopus laevis
4.
J Gen Physiol ; 132(6): 633-50, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19029372

ABSTRACT

After removal of the fast N-type inactivation gate, voltage-sensitive Shaker (Shaker IR) K channels are still able to inactivate, albeit slowly, upon sustained depolarization. The classical mechanism proposed for the slow inactivation observed in cell-free membrane patches--the so called C inactivation--is a constriction of the external mouth of the channel pore that prevents K(+) ion conduction. This constriction is antagonized by the external application of the pore blocker tetraethylammonium (TEA). In contrast to C inactivation, here we show that, when recorded in whole Xenopus oocytes, slow inactivation kinetics in Shaker IR K channels is poorly dependent on external TEA but severely delayed by internal TEA. Based on the antagonism with internally or externally added TEA, we used a two-pulse protocol to show that half of the channels inactivate by way of a gate sensitive to internal TEA. Such gate had a recovery time course in the tens of milliseconds range when the interpulse voltage was -90 mV, whereas C-inactivated channels took several seconds to recover. Internal TEA also reduced gating charge conversion associated to slow inactivation, suggesting that the closing of the internal TEA-sensitive inactivation gate could be associated with a significant amount of charge exchange of this type. We interpreted our data assuming that binding of internal TEA antagonized with U-type inactivation (Klemic, K.G., G.E. Kirsch, and S.W. Jones. 2001. Biophys. J. 81:814-826). Our results are consistent with a direct steric interference of internal TEA with an internally located slow inactivation gate as a "foot in the door" mechanism, implying a significant functional overlap between the gate of the internal TEA-sensitive slow inactivation and the primary activation gate. But, because U-type inactivation is reduced by channel opening, trapping the channel in the open conformation by TEA would also yield to an allosteric delay of slow inactivation. These results provide a framework to explain why constitutively C-inactivated channels exhibit gating charge conversion, and why mutations at the internal exit of the pore, such as those associated to episodic ataxia type I in hKv1.1, cause severe changes in inactivation kinetics.


Subject(s)
Ion Channel Gating/drug effects , Ion Channel Gating/physiology , Kv1.4 Potassium Channel/drug effects , Kv1.4 Potassium Channel/metabolism , Tetraethylammonium/pharmacology , Allosteric Site/drug effects , Allosteric Site/physiology , Animals , Cytoplasm/metabolism , Electrophysiology , Energy Transfer/physiology , Female , Kv1.4 Potassium Channel/genetics , Membrane Potentials , Mice , Oocytes , Potassium/metabolism , Potassium Channel Blockers/metabolism , Potassium Channel Blockers/pharmacology , Protein Interaction Domains and Motifs/drug effects , Protein Interaction Domains and Motifs/genetics , Structure-Activity Relationship , Tetraethylammonium/metabolism , Thermodynamics , Xenopus laevis
5.
Pharmazie ; 63(6): 475-9, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18604993

ABSTRACT

As the major component of I(to) (slow), Kv1.4 channel plays an important role in repolarization of cardiac myocytes. C-type inactivation is one of Kv1.4 inactivation and can be affected by open channel blockers. We used the two-electrode voltage clamp technique to observe the effect of amiodarone on Kv1.4 C-type inactivation and compare amiodarone's effects on Kv1.4 with propafenone and verapamil. Our data show that those three antiarrhythmic drugs blocked fKv1.4 delta N (N-terminal deleted Kv1.4 channel from ferret heart) in voltage- and frequent-dependent manners. The amiodarone's IC50 was 489.23 +/- 4.72 microM, higher than that of propafenone (98.97 +/- 1.13 microM) and verapamil (263.26 +/- 6.89 microM) for fKv1.4 delta N channel (+50 mV). After application of amiodarone, propafenone and verapamil, fKv1.4 delta N inactivation becomes bi-exponential: the faster portion of inactivation (drug-induced inactivation) and the slower portion of inactivation (C-type inactivation). Amiodarone and verapamil fastened C-type inactivation in fKv1.4 delta N, but propafenone did not. Unlike propafenone that had no effect on fKv1.4 delta N recovery, amiodarone and verapamil slowed recovery in fKv1.4 delta N.


Subject(s)
Amiodarone/pharmacology , Anti-Arrhythmia Agents/pharmacology , Calcium Channel Blockers/pharmacology , Kv1.4 Potassium Channel/drug effects , Propafenone/pharmacology , Verapamil/pharmacology , Xenopus Proteins/drug effects , Animals , DNA, Complementary/biosynthesis , DNA, Complementary/genetics , Dose-Response Relationship, Drug , Electrophysiology , Female , Oocytes/drug effects , Oocytes/metabolism , Patch-Clamp Techniques , Xenopus laevis
6.
Biochem Biophys Res Commun ; 370(3): 445-9, 2008 Jun 06.
Article in English | MEDLINE | ID: mdl-18375201

ABSTRACT

Redox modulation of fast inactivation has been described in certain cloned A-type voltage-gated K(+) (Kv) channels in expressing systems, but the effects remain to be demonstrated in native neurons. In this study, we examined the effects of cysteine-specific redox agents on the A-type K(+) currents in acutely dissociated small diameter dorsal root ganglion (DRG) neurons from rats. The fast inactivation of most A-type currents was markedly removed or slowed by the oxidizing agents 2,2'-dithio-bis(5-nitropyridine) (DTBNP) and chloramine-T. Dithiothreitol, a reducing agent for the disulfide bond, restored the inactivation. These results demonstrated that native A-type K(+) channels, probably Kv1.4, could switch the roles between inactivating and non-inactivating K(+) channels via redox regulation in pain-sensing DRG neurons. The A-type channels may play a role in adjusting pain sensitivity in response to peripheral redox conditions.


Subject(s)
Chloramines/pharmacology , Ganglia, Spinal/drug effects , Kv Channel-Interacting Proteins/drug effects , Neurons, Afferent/drug effects , Oxidants/pharmacology , Pain/physiopathology , Pyridines/pharmacology , Tosyl Compounds/pharmacology , Animals , Cysteine/drug effects , Dithiothreitol/pharmacology , Ganglia, Spinal/cytology , Ganglia, Spinal/metabolism , Kv Channel-Interacting Proteins/metabolism , Kv1.4 Potassium Channel/drug effects , Kv1.4 Potassium Channel/metabolism , Neurons, Afferent/metabolism , Oxidation-Reduction , Rats , Rats, Wistar
7.
Neuroreport ; 19(4): 491-6, 2008 Mar 05.
Article in English | MEDLINE | ID: mdl-18287954

ABSTRACT

Sharp wave-ripple complexes (SPW-Rs) are characterized by approximately 60 ms field potential transients superimposed by ripple oscillations of approximately 200 Hz. In chronic epileptic rodents and humans, faster ripples have been recorded showing frequencies of up to 500 Hz. In this study, we tested whether the blockade of K currents by 4-aminopyridine (4-AP) contribute to the generation of high-frequency ripples, as changes in K channel expression have been observed in chronic epileptic tissue. We showed that 4-AP significantly increased the amplitudes and incidence of induced SPW-Rs without significantly changing their ripple frequency. alpha-Dendrotoxin or BDS-I did not mimick these changes suggesting that 4-AP acts via Kv1.4 channels. Thus, the incidence of SPW-Rs, but not the ripple frequency is regulated by 4-AP-sensitive potassium currents.


Subject(s)
4-Aminopyridine/pharmacology , Action Potentials/drug effects , Hippocampus/drug effects , Neurons/drug effects , Potassium Channels/drug effects , Action Potentials/physiology , Animals , Biological Clocks/drug effects , Biological Clocks/physiology , Evoked Potentials/drug effects , Evoked Potentials/physiology , Female , Hippocampus/metabolism , Kv1.4 Potassium Channel/drug effects , Kv1.4 Potassium Channel/metabolism , Male , Neurons/metabolism , Organ Culture Techniques , Potassium/metabolism , Potassium Channel Blockers/pharmacology , Potassium Channels/metabolism , Pyramidal Cells/drug effects , Pyramidal Cells/metabolism , Rats , Rats, Wistar , Time Factors
8.
Cardiovasc Res ; 71(3): 430-42, 2006 Aug 01.
Article in English | MEDLINE | ID: mdl-16762331

ABSTRACT

Transient outward channels have a different impact on action potential configuration in small mammals compared to large mammals. Small mammals depend primarily on Ito1 for repolarization, while in larger animals Ito1 only indirectly determines action potential duration by setting the level of the plateau. Transient outward channel expression and distribution also differ between animal species. Nevertheless, the primary protein sequence of the underlying Kv1.4, Kv4.2 and Kv4.3 alpha1-subunits displays remarkably high levels of amino acid identity. Transient outward channels are subject to alpha- and beta-adrenergic regulation, mainly decreasing Ito1. However, adrenergic stimulation is also an important determinant of transient outward channel downregulation in cardiac disease. Adrenergic stimulation of PKA as well as PKC leads to an inhibition of Ito1, which has been correlated with phosphorylation of the Kv1.4, Kv4.2 and Kv4.3 alpha1-subunits. Calmodulin-dependent kinase II, on the other hand, has been shown to be involved in an increase of Ito1. Comparison of Kv1.4, Kv4.2 and Kv4.3 primary amino acid sequences demonstrates a strong conservation of (potential) phosphorylation sites between different species, despite the fact that Ito1 has a different effect on action potential configuration in mammalian species.


Subject(s)
Adrenergic Agents/pharmacology , Kv1.4 Potassium Channel/drug effects , Shal Potassium Channels/drug effects , Action Potentials/drug effects , Amino Acid Sequence , Animals , Heart Diseases/physiopathology , Kv1.4 Potassium Channel/genetics , Molecular Sequence Data , Phosphorylation , Protein Kinases/physiology , Sequence Alignment , Shal Potassium Channels/genetics , Species Specificity
9.
Mol Hum Reprod ; 11(12): 891-7, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16421215

ABSTRACT

Fertility depends in part on the ability of the spermatozoon to respond to osmotic challenges by regulating its volume, which may rely on the movement of K+. These experiments were designed to characterize the K+ channels possibly involved in volume regulation of human ejaculated spermatozoa by simultaneously exposing them to a physiological hypo-osmotic challenge and a wide range of K+ channel inhibitors. Regulation of cellular volume, as measured by flow cytometry, was inhibited when spermatozoa were exposed to quinine (QUI; 0.3 mM), 4-aminopyridine (4AP; 4 mM) and clofilium (CLO; 10 microM) which suggests the involvement of voltage-gated K+ channels Kv1.4, Kv1.5 and Kv1.7, acid-sensitive channel TASK2 and the beta-subunit minK (IsK) in regulatory volume decrease (RVD). QUI and 4AP and, to some extent, CLO also induced hyper activation-like motility. A sensitivity of RVD to pH could not be demonstrated in spermatozoa to support the involvement of TASK2 channels. Western blotting indicated the presence of Kv1.5, TASK2, TASK3 and minK channel proteins, but not Kv1.4. Furthermore, Kv1.5, minK and TASK2 were localized to various regions of the spermatozoa. Although Kv1.4, Kv1.7, TASK2 and TASK3 channels may have important roles in human spermatozoa, Kv1.5 and minK appear to be the most likely candidates for human sperm RVD, serving as targets for non-hormonal contraception.


Subject(s)
Potassium Channels/physiology , Spermatozoa/cytology , Spermatozoa/physiology , 4-Aminopyridine/pharmacology , Cell Size , Flow Cytometry , Humans , Kv1.4 Potassium Channel/drug effects , Kv1.4 Potassium Channel/physiology , Kv1.5 Potassium Channel/drug effects , Kv1.5 Potassium Channel/physiology , Male , Potassium Channels/drug effects , Quaternary Ammonium Compounds/pharmacology , Quinine/pharmacology , Shaker Superfamily of Potassium Channels/drug effects , Shaker Superfamily of Potassium Channels/physiology , Spermatozoa/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...